TheEdgeResearch
Home / Stocks / IDBA

IDEX Biometrics ASA (IDBA)

NASDAQ Technology Semiconductors
$4.88 ▲ +1.67%
Market Cap
$90.8M
Sector
Technology
Industry
Semiconductors
Beta
1.97
52-Wk Range
4.33-11.15
CEO
Vincent Graziani
Country
NO
Currency
USD

IDEX Biometrics ASA operates in the Semiconductors industry of the Technology sector, headquartered in Oslo, NO. The stock last traded at $4.88, up 1.67% on the session, giving a market capitalisation of $90.8M. On trailing twelve-month figures it carries a trailing P/E of -4.56, a net margin of -643.4%. Its beta of 1.97 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-4.56
Price / Sales
21.87
Price / Book
108.61
EV / EBITDA
-0.32
Gross margin
5.6%
Operating margin
-648.6%
Net margin
-643.4%
Return on equity
Debt / equity
0.61
Current ratio
1.64
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Capital Market
Employees
79
IPO date
2021-03-01
Headquarters
Oslo, NO
About IDEX Biometrics ASA

IDEX Biometrics ASA specializes in the creation, enhancement, and global distribution of fingerprint authentication technologies. Its operations span diverse regions including Europe, the Middle East, Africa, the Americas, and Asia-Pacific. These cutting-edge solutions are primarily integrated into contactless financial payment systems, secure access control mechanisms, and a variety of smart card applications. Additionally, their technology facilitates card-based devices used for storing digital currencies. The company's core focus is serving manufacturers of smart cards, particularly those active within the financial payment and emerging biometric payment card industries. Established in 1996, IDEX Biometrics ASA maintains its corporate headquarters in Oslo, Norway.

Comparable companies

IDEX Biometrics ASA is most often compared with the following Technology names:

CIHCPTNDPSIEMBKKLRMKFGPSQHSNCRSTIX
More research on IDBA
IDBA technical analysis IDBA TheEdge Score Compare against peers
Open full interactive analysis & DCF →